Further research is "urgently needed" to set up a successful screening process in order to prevent prostate cancer, a leading scientist has said.
Professor Fritz Schroder, who lead a major study into prostate screening, said more research was needed to reduce the number of men "screened, biopsied, and treated".
PSA screening delivers a substantial reduction in prostate cancer deaths, similar or greater than that reported in screening for breast cancer.
However, over-diagnosis occurs in roughly 40% of cases detected by screening resulting in a high risk of over-treatment and common side-effects such as incontinence and impotence.
The time for population-based screening has not arrived.
Further research is urgently needed on ways to reduce over-diagnosis preferably by avoiding unnecessary biopsy procedures, and reducing the very large number of men who must be screened, biopsied, and treated to help only a few patients.
More top news
Showers could be heavy for a time but most should still enjoy sunny spells.
The chief executive of EDF has urged the government to go ahead with the new nuclear plant.
An Italian prosecutor investigating the quake aftermath believes cheap renovations may be partly to blame for the high death toll.